Improving the quality of life for people with ALS: The challenge ahead

Amyotrophic Lateral Sclerosis

Volumn 1, Issue 5, 2000, Pages 329-336

  Mitsumoto, Hiroshi ^a   Del Bene, Maura ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

ALS; management; psychosocial; quality of life

Indexed keywords

ATTITUDE TO HEALTH; CAREGIVER; ENTERIC FEEDING; EXERCISE; FAMILY; HOSPICE CARE; HUMAN; MOTOR NEURON DISEASE; PATIENT CARE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW;

ATTITUDE TO HEALTH; CAREGIVERS; ENTERAL NUTRITION; EXERCISE; FAMILY; HOSPICE CARE; HUMANS; MOTOR NEURON DISEASE; PATIENT CARE TEAM; QUALITY OF LIFE;

EID: 0034575199     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/146608200300079464     Document Type: Article

References (46)

1. Ruta DA, Carratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life: the patient-generated index. Med Care 1994; 32: 1109-1126.
2. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994; 272: 619-626. (Pubitemid 24255222)
3. Murrell R. Quality of life and neurological illness: a review of the literature. Neuropsychol Rev (in press).
4. Lai EC, Felice KJ, Festoff BW, et al. Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. Neurology 1997; 49: 1621-1630. (Pubitemid 28015128)
5. McGuire D, Garrison L, Armon C, et al. A brief quality-of-life measure for ALS clinical trials. Based on a subset of items from the sickness impact profile. J Neurol Sci 1997; 152:S18-S22. (Pubitemid 27505285)
6. Miller RG, Anderson F, ALS C.A.R.E Study Group. Assessing Quality of Life in ALS: Comparison of the Short Form-12 Health Survey™ with the ALS Functional Rating Scale, Forced Vital Capacity, and ALS Quality of Life Index. 8th International Symposium on ALS/MND; November 3-5, 1997, Glasgow, Scotland [poster].
7. Wright L. The long and the short of it: development of the SF-36 general health survey. In: Jenkinson C (Ed). Measuring Health and Medical Outcomes. London UCL Press, 1994.
8. BDNF Study Group (Phase III). A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 1999; 52: 1427-1433.
9. Miller RG, Anderson F, Bradley W, et al. The ALS Patient Care Database I: Goals, structure and early results. Neurology 2000; 54: 53-57. (Pubitemid 30038737)
10. Simmons Z, Robbins RA, Bremer BA, et al. Longitudinal relationship between quality of life, physical function, and spirituality in patients with ALS. 10th International Symposium of ALS/MND, Vancouver 1999: 9-10 (abstr).
11. O'Boyle C, McGee H, Hickey A, O'Maley K, Joyce CRB. Individual quality of life in patients undergoing hip-replacement. Lancet 1992; 339: 1088-1091.
12. Jenkinson C, Fitzpatrick R, Brennan C, Swash M. Evidence for the validity and reliability of the ALS assessment questionnaire: The ALSAQ-40. ALS 1999; 1: 33-40.
13. ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996; 53: 141-147.
14. Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: an evidence-based review. Neurology 1999; 52: 1311-1323.
15. Beisecker AE, Kuckelmann-Cobb A, Ziegler DK. Patients' perspectives of the role of care providers in amyotrophic lateral sclerosis. Arch Neurol 1988; 45: 553-556.
16. Mitsumoto H, Chad DA, Pioro EP. Comprehensive care; and medical economics, legality, and medical ethics in ALS. In: Amyotrophic Lateral Sclerosis. Contemporary Neurology Series 49. New York: Oxford Press, 1998: 305-320; 448-464.
17. Mitsumoto H, Shockley L. Amyotrophic lateral sclerosis: continuum of care from diagnosis through hospice. Home Health Care Consultant 1998; 5: 20-29.
18. Mitsumoto H. and Norris FT, Jr. Amyotrophic Lateral Sclerosis: Comprehensive Management and Treatment. New York: Demos, 1994.
19. Dal Bello-Haas V, Kloos AD, Mitsumoto H. Physical therapy for a patient through six stages of amyotrophic lateral sclerosis. Phys Ther 1998; 78: 1312-1324. (Pubitemid 28565309)
20. Mitsumoto H. Patient choices in ALS: Life-sustaining treatment versus palliative care? Neurology 1999; 53: 248-249. (Pubitemid 29344341)
21. Lacomblez L, Bensimon G, Leigh NP, et al for the Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Doseranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996; 347: 1425-1431. (Pubitemid 26161204)
22. Miller RG, Suit R, Mitsumoto H, Gelinus DF, Brooks BR. ALS standard of care consensus. Neurology 1997; 48(Suppl 4): S33-S37. (Pubitemid 27172943)
23. Mitsumoto H. Riluzole - what is its impact in our treatment and understanding of amyotrophic lateral sclerosis? Ann Pharmacother 1997; 31: 779-781. (Pubitemid 27242392)
24. Norris FH. Treating the untreated. Br Med J 1992; 304: 459-460
25. Mazzini L, Corra T, Zaccala M, Mora G, DelPiano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995; 242: 695-698.
26. Kasarskis EJ, Scarlata D, Hill R, et al. A retrospective study of percutaneous endoscopic gastrostomy. I ALS patients during the BDNF and CNTF trials. J Neurol Sci 1999; 169: 118-125. (Pubitemid 29502518)
27. Aboussaouan LS, Khan SU, Meeker DP, Stelmack K, Mitsumoto H. The effect of non-invasive positive pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997; 127: 450-453. (Pubitemid 27400908)
28. Kleopa KA, Sherman M, Neil B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 1999; 164: 82-88. (Pubitemid 29256079)
29. Melo J, Homma A, Iturriag E, et al. Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: a multicenter survey and proposal of a pulmonary protocol. J Neurol Sci 1999; 169: 114-117. (Pubitemid 29502517)
30. Pinto AC, Evangelista T, Carvalho M, et al. Respiratory assistance with a non-invasive ventilator (BiPAP) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci 1995; 129 (suppl): 19-26.
31. Sivak ED, Shefner JM, Mitsumoto H. The use of noninvasive positive pressure ventilation (NIPPV) in the treatment of respiratory failure in ALS patients. A need for better deinition of timing of the goals of intervention. J Neurol Sci (in press).
32. Aboussouan LS, Khan SU, Arroliga AC, Banerji M, Mitsumoto H. Effect of non-invasive pressure ventilation on pulmonary function in ALS. Chest 1999; 116: 271S.
33. Albert SM, Murphy PL, Del Bene ML, Rowland LP. Prospective study of palliative care in ALS: choice, timing, outcomes. J Neurol Sci 1999; 169: 108-113. (Pubitemid 29502516)
34. Albert SM, Murphy PL, DelBene MI, Rowland LP. A prospective study of preferences and actual treatment choices in ALS. Neurology 1999; 53: 273-284.
35. Mandler RN, Clawson LL, Miller RG, and the ALS C.A.R.E. Study Group. The ALS Patient Care Database - Insights into end-of-life palliative care. American Neurological Association 124th Annual Meeting, Seattle, Washington, 1999 [poster].
36. Moss AH, Casey P, Stocking CB, et al. Home ventilator for amyotrophic lateral sclerosis patient: outcomes, costs, and patients, family, and physician attitude. Neurology 1993; 43: 438-443.
37. Kowa H. Home care system in amyotrophic lateral sclerosis. Neurol Therap (Tokyo) 1993; 10: 279-283.
38. Krivickas LS, Shockley L, Mitsumoto H. Home care of patients with amyotrophic lateral sclerosis (ALS). J Neurol Sci 1997; 152 (Suppl 1): S82-S89. (Pubitemid 27505297)
39. Borasio GD, Voltz R. Palliative care in amyotrophic lateral sclerosis. J Neurol 1997; 244 (suppl 4): S11-S17.
40. O'Brien T. Palliative care and taboos within motor neurone disease. Palliat Med 1993; 7(suppl 2): 69-72. (Pubitemid 23322800)
41. McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in amyotrophic lateral sclerosis. Arch Neurol 1994; 51: 17-23.
42. Rabkin JG, Wagner GJ, Del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med (in press).
43. Lyon M. Living with ALS - HOPE. LINK 1998; 12.
44. Miller RG, Munsat TL, Swash M, Brooks BR. Consensus guidelines for the design and implementation of clinical trials in ALS. J Neurol Sci 1999; 196: 2-12. (Pubitemid 29502500)
45. Bach JR. Ventilator use by muscular dystrophy association patients. Arch Phys Med Rehabil 1992; 73: 179-183.
46. Anderson FA Jr, Miller RG, ALS CARE Advisory board. A resource for measuring and improving ALS outcomes. Neurology 1996; 47 (suppl 2): S113-S116. (Pubitemid 26362008)